|
業務類別
|
-- |
|
業務概覽
|
Semnur Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its main product candidate, SP-102 (10mg, dexamethasone sodium phosphate viscous gel), is being developed as a non-opioid novel injectable corticosteroid gel formulation for patients with moderate to severe LRP (also known as sciatica), containing no preservatives, surfactants, solvents, or particulates. |
| 公司地址
| 960 San Antonio Road, Palo Alto, CA, USA, 94303 |
| 電話號碼
| +1 650 422-7515 |
| 傳真號碼
| +1 650 397-6759 |
| 公司網頁
| https://www.semnurpharma.com |
| 員工數量
| 10 |
| Mr. Jaisim Shah |
Director, Chief Executive Officer and President |
-- |
11/06/2025 |
| Dr. Henry Ji,PhD |
Executive Chairman of the Board, Treasurer and Secretary |
-- |
11/06/2025 |
| Mr. Stephen Ma |
Chief Financial Officer, Senior Vice President and Secretary |
-- |
11/06/2025 |
|
|
| Mr. Jaisim Shah |
Director, Chief Executive Officer and President |
11/06/2025 |
| Dr. Henry Ji,PhD |
Executive Chairman of the Board, Treasurer and Secretary |
11/06/2025 |
| Dr. Yue Alexander Wu, PhD |
Independent Director |
21/04/2025 |
| Mr. Dorman Followwill |
Independent Director |
11/06/2025 |
| Dr. Jay Chun, M.D.,PhD |
Independent Director |
21/04/2025 |
|
|
|
|
